Human neutrophil peptides as biomarkers for monitoring respiratory functional impairment in sarcoidosis

G. Paone, M. Rulli, A. Leone, P. Graziano, V. Conti, I. Cammarella, G. Galluccio, A. Sebastiani, G. Lucantoni, G. Puglisi (Rome, Milan, Italy)

Source: Annual Congress 2011 - Cell biology of lung disease
Session: Cell biology of lung disease
Session type: Thematic Poster Session
Number: 3883
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Paone, M. Rulli, A. Leone, P. Graziano, V. Conti, I. Cammarella, G. Galluccio, A. Sebastiani, G. Lucantoni, G. Puglisi (Rome, Milan, Italy). Human neutrophil peptides as biomarkers for monitoring respiratory functional impairment in sarcoidosis. Eur Respir J 2011; 38: Suppl. 55, 3883

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Human neutrophil peptides as biotracers of functional impairment in COPD smokers
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003

Decline in lung function in patients with alpha-1-antitrypsin deficiency and airflow obstruction
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014

Relationship of airway structural changes and lung function abnormalities with blood and BAL biomarkers in asthma
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019



Role of the lung volume measurement in the diagnosis of obstructive diseases in patients with restrictive ventilatory impairment
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014

Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


Measuring function – lung function testing in paediatric respiratory disease
Source: Annual Congress 2004 - PG5 - Objective assessments in paediatric respiratory medicine
Year: 2004

The [bdquo]frequent exacerbator“ phenotype: Endothelial dysfunction and functional status
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014


A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019
Year: 2019



The relationship between the clinical symptoms, BALF cells and indices of respiratory function in patients with newly diagnosed sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 534s
Year: 2004

Development of a biomarker for lung inflammation in COPD through analysis of labeled leukocyte transit through the lung circulation
Source: Eur Respir J 2006; 28: Suppl. 50, 672s
Year: 2006

Small airway dysfunction is associated to the excessive bronchoconstriction in asthma
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014

Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017



Development of a biomarker for lung inflammation in COPD through analysis of labelled leukocyte transit through the lung circulation
Source: Eur Respir Rev 2006; 15: 170-171
Year: 2006



Analysis of the rheological properties of respiratory mucus and inflammatory alterations of the airways in patients with common variable immunodeficiency associated with bronchiectasis
Source: Eur Respir J 2006; 28: Suppl. 50, 444s
Year: 2006

Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

The evaluation of respiratory muscle functions in patients with severe COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 288s
Year: 2004

Correlation of clinical, laboratory and functional parameters in stable chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

Prognostic significance of respiratory symptoms in individuals with preserved pulmonary function without known airway disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019